U.S. Food and Drug Administration
horizontal rule

FDA Nanotechnology Task Force

About the Task Force

The FDA Nanotechnology Task Force, formed in August 2006, is charged with determining regulatory approaches that encourage the continued development of innovative, safe, and effective FDA-regulated products that use nanotechnology materials. The Task Force will identify and recommend ways to address any knowledge or policy gaps that exist so as to better enable the agency to evaluate possible adverse health effects from FDA-regulated products that use nanotechnology materials.

Task Force Report - July 2007 [pdf version, 287 KB]

FDA Nanotechnology Task Force Press Release (August 9, 2006)

FDA Nanotechnology Task Force Members

Other Nanotechnology Information

FDA Nanotechnology Public Meeting (September 8, 2008)

FDA Nanotechnology Public Meeting (Oct. 10, 2006)

FDA Nanotechnology Page

National Nanotechnology Initiative

Public Docket

View comments submitted to Nanotechnology Public Docket

rule

PDF documents may be read with a free copy of the Adobe Acrobat Reader.

rule link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page